Responses
Clinical and epidemiological research
Extended report
Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
Compose a Response to This Article
Other responses
No responses have been published for this article.